Total Payments
$16,710
2024 Payments
$901.19
Companies
44
Transactions
568
Medicare Patients
16,620
Medicare Billing
$1.8M
Payment Breakdown by Category
Food & Beverage$9,368 (56.1%)
Education$6,194 (37.1%)
Gifts$487.00 (2.9%)
Travel$345.23 (2.1%)
Other$300.00 (1.8%)
Consulting$15.19 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,368 | 552 | 56.1% |
| Education | $6,194 | 9 | 37.1% |
| Gift | $487.00 | 2 | 2.9% |
| Travel and Lodging | $345.23 | 3 | 2.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $300.00 | 1 | 1.8% |
| Consulting Fee | $15.19 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $6,832 | 7 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,764 | 136 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,451 | 75 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,219 | 66 | $0 (2023) |
| Mylan Specialty L.P. | $864.96 | 52 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $636.66 | 46 | $0 (2019) |
| Insmed, Inc. | $594.60 | 32 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $541.88 | 21 | $0 (2024) |
| Pinnacle Biologics, Inc | $300.00 | 1 | $0 (2022) |
| Actelion Pharmaceuticals US, Inc. | $296.27 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $901.19 | 41 | GlaxoSmithKline, LLC. ($179.86) |
| 2023 | $8,228 | 75 | Intuitive Surgical, Inc. ($6,832) |
| 2022 | $1,628 | 76 | Pinnacle Biologics, Inc ($300.00) |
| 2021 | $1,451 | 94 | Boehringer Ingelheim Pharmaceuticals, Inc. ($247.61) |
| 2020 | $1,052 | 68 | AstraZeneca Pharmaceuticals LP ($228.33) |
| 2019 | $1,335 | 85 | Sunovion Pharmaceuticals Inc. ($288.01) |
| 2018 | $1,480 | 91 | GlaxoSmithKline, LLC. ($400.29) |
| 2017 | $633.69 | 38 | GlaxoSmithKline, LLC. ($191.01) |
All Payment Transactions
568 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $8.69 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.36 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 10/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.08 | General |
| Category: Immunology | ||||||
| 10/01/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Respiratory | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $0.64 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: RESPIRATORY | ||||||
| 09/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.08 | General |
| Category: Immunology | ||||||
| 08/27/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: RESPIRATORY | ||||||
| 08/21/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Cardiology | ||||||
| 08/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $27.86 | General |
| Category: RESPIRATORY | ||||||
| 08/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.35 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/01/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: RESPIRATORY | ||||||
| 07/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: IMMUNOLOGY | ||||||
| 07/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: RESPIRATORY | ||||||
| 06/19/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $38.02 | General |
| Category: IMMUNOLOGY | ||||||
| 05/30/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Pulmonology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 4,805 | 7,454 | $2.4M | $511,932 |
| 2022 | 18 | 4,584 | 6,814 | $2.1M | $484,089 |
| 2021 | 19 | 3,928 | 6,103 | $1.7M | $415,192 |
| 2020 | 17 | 3,303 | 5,507 | $1.5M | $347,414 |
Total Patients
16,620
Total Services
25,878
Medicare Billing
$1.8M
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 981 | 2,964 | $1.0M | $228,900 | 22.1% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 89 | 91 | $170,590 | $40,993 | 24.0% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 83 | 83 | $165,281 | $38,171 | 23.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 154 | 371 | $142,835 | $33,816 | 23.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 277 | 278 | $155,560 | $32,091 | 20.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 604 | 630 | $85,923 | $25,632 | 29.8% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 604 | 630 | $98,165 | $24,327 | 24.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 123 | 134 | $87,100 | $17,658 | 20.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 604 | 630 | $120,055 | $16,899 | 14.1% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 46 | 251 | $56,475 | $14,242 | 25.2% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 30 | 134 | $40,200 | $10,913 | 27.1% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 533 | 550 | $64,998 | $6,866 | 10.6% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 259 | 271 | $37,940 | $6,237 | 16.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 249 | 255 | $28,050 | $4,723 | 16.8% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 26 | 26 | $11,310 | $2,648 | 23.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 35 | $7,875 | $2,120 | 26.9% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 17 | 17 | $32,640 | $1,537 | 4.7% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 15 | 15 | $28,693 | $1,407 | 4.9% |
| 94762 | Test to measure oxygen level in blood using ear or finger device continuously overnight | Office | 2023 | 59 | 60 | $5,400 | $1,054 | 19.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 18 | $4,050 | $999.84 | 24.7% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 11 | 11 | $5,720 | $700.90 | 12.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 858 | 2,666 | $932,430 | $226,408 | 24.3% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 112 | 113 | $216,960 | $51,084 | 23.5% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 96 | 99 | $198,856 | $46,432 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 234 | 234 | $129,840 | $27,932 | 21.5% |
About Dr. Amir Khan, MD
Dr. Amir Khan, MD is a Critical Care Medicine healthcare provider based in Waxahachie, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2009. The National Provider Identifier (NPI) number assigned to this provider is 1467680868.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amir Khan, MD has received a total of $16,710 in payments from pharmaceutical and medical device companies, with $901.19 received in 2024. These payments were reported across 568 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($9,368).
As a Medicare-enrolled provider, Khan has provided services to 16,620 Medicare beneficiaries, totaling 25,878 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Waxahachie, TX
- Active Since 06/24/2009
- Last Updated 03/04/2020
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1467680868
Products in Payments
- Da Vinci Surgical System (Device) $3,832
- ION (Device) $3,000
- DUPIXENT (Biological) $886.99
- TRELEGY ELLIPTA (Drug) $822.09
- OFEV (Drug) $728.19
- Yupelri (Drug) $723.42
- Arikayce (Drug) $594.60
- NUCALA (Biological) $586.00
- STIOLTO RESPIMAT (Drug) $508.13
- LONHALA MAGNAIR (Drug) $453.92
- FASENRA (Drug) $394.77
- Photofrin (Drug) $300.00
- BREZTRI (Drug) $232.99
- FASENRA (Biological) $232.52
- OPSUMIT (Drug) $198.59
- ANORO (Drug) $197.68
- ACTHAR (Biological) $174.46
- SYMBICORT (Drug) $154.68
- SPIRIVA (Drug) $141.90
- BEVESPI AEROSPHERE (Drug) $125.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.